Charles T. Robbins

Environmental ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability”.

An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability

PLoS Biology(2021)10.1371/journal.pbio.3000797

N/A

0.550DataRank · unranked

38 citations

Darren R. Tyson, Charles T. Robbins, Peter L. Frick, Vito Quaranta, Leonard A. Harris +1 more

Multi-Institutional Study of Pathologist Reading of the Programmed Cell Death Ligand-1 Combined Positive Score Immunohistochemistry Assay for Gastric or Gastroesophageal Junction Cancer

Modern Pathology(2023)10.1016/j.modpat.2023.100128

N/A

0.494DataRank · unranked

26 citations

Charles T. Robbins, Patricia Gaule, Diana Agostini‐Vulaj, Robert A. Anders, Andrew M. Bellizzi +16 more

An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells

Cancer Research(2020)10.1158/0008-5472.can-19-3588

N/A

0.449DataRank · unranked

19 citations

Joshua E. Lewis, Keisha N. Hardeman, Corey E. Hayford, Charles T. Robbins, Philip E. Stauffer +6 more

Multi-institutional Assessment of Pathologist scoring HER2 Immunohistochemistry

Research Square(2022)10.21203/rs.3.rs-1763087/v1

N/A

0DataRank · unranked

7 citations

Aileen I. Fernandez, Han Gan, Serena Wong, Malini Harigopal, Mirna Podoll +17 more

Real-time luminescence enables continuous drug-response analysis in adherent and suspension cell lines

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.479010

N/A

0DataRank · unranked

0 citations

Charles T. Robbins, Darren R. Tyson, Leonard A. Harris, Vito Quaranta, Clayton M. Wandishin

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Modern Pathology(2023)10.1016/j.modpat.2022.100032

N/A

0DataRank · unranked

99 citations

Aileen I. Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll +17 more

Validation and Prospective Testing of a High Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides

medRxiv(2025)10.1101/2025.05.06.25327097

N/A

0DataRank · unranked

0 citations

Patricia Gaule, Julia Benanto, Liam Scott, Charles T. Robbins, Mengni He +6 more

Prospective Assessment of a Quantitative Immunofluorescent Assay to Measure HER2 and TROP2 concentrations on a Single Tissue Biopsy Slide

Research Square(2025)10.21203/rs.3.rs-7785005/v1

N/A

0DataRank · unranked

0 citations

Julia Benanto, Liam Scott, Mengni He, Charles T. Robbins, Daniel C. Liebler +3 more

A unifying framework disentangles genetic, epigenetic, and stochastic sources of drug-response variability in an in vitro model of tumor heterogeneity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.05.136119

N/A

0DataRank · unranked

3 citations

Darren R. Tyson, Charles T. Robbins, Peter L. Frick, Vito Quaranta, Leonard A. Harris +1 more

Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines

Cancer Biology & Therapy(2022)10.1080/15384047.2022.2065182

N/A

0DataRank · unranked

3 citations

Charles T. Robbins, Darren R. Tyson, Leonard A. Harris, Vito Quaranta, Clayton M. Wandishin